OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Cowen And Company 34th Annual Health Care Conference
2/28/2014 9:57:19 AM
REDWOOD CITY, Calif., Feb. 28, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that Paul J. Hastings, OncoMed's Chairman and Chief Executive Officer, will speak at the Cowen and Company 34th Annual Health Care Conference being held at the Boston Marriott Copley Place in Boston, MA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by